A profitable company with growing sales.
Facts from SEC filings, not a recommendation.
From GS's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $66.2B, up 18% from the 12 months before. Over 5 years, sales grew about 5.5% a year.
Move the sliders to your own view of GS. Starting points are the company's recent numbers.
What today's price needs: with a 32% margin and a 14x P/E, sales could shrink about 6.5% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. Not in this company's SEC data, so not scored: debt under half of equity. A checklist is a starting point for research, not a verdict.
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
SEC filings of any kind. 50 means a normal week.
Institutions added 0.3% to their holdings. 1488 bought, 1215 sold.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
Ericka T LeslieChief Administrative Officer | Sell | 250 | $890.25 | $223K | 11K | Oct 22Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page